NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
0.6801
Dollar change
-0.0199
Percentage change
-2.84
%
Index- P/E- EPS (ttm)-8.90 Insider Own0.81% Shs Outstand4.80M Perf Week-3.04%
Market Cap3.26M Forward P/E- EPS next Y-0.93 Insider Trans0.00% Shs Float4.76M Perf Month-1.05%
Enterprise Value-3.91M PEG- EPS next Q-0.55 Inst Own5.43% Short Float23.46% Perf Quarter-1.25%
Income-13.14M P/S- EPS this Y85.62% Inst Trans0.21% Short Ratio3.79 Perf Half Y-60.23%
Sales0.00M P/B0.56 EPS next Y36.52% ROA-126.10% Short Interest1.12M Perf YTD-58.78%
Book/sh1.21 P/C0.45 EPS next 5Y55.06% ROE-170.72% 52W High4.89 -86.09% Perf Year-85.15%
Cash/sh1.51 P/FCF- EPS past 3/5Y84.12% 77.35% ROIC-246.50% 52W Low0.60 13.35% Perf 3Y-99.80%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility4.98% 7.29% Perf 5Y-99.98%
Dividend TTM- EV/Sales- EPS Y/Y TTM63.97% Oper. Margin- ATR (14)0.05 Perf 10Y-100.00%
Dividend Ex-Date- Quick Ratio2.81 Sales Y/Y TTM-100.00% Profit Margin- RSI (14)47.26 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.81 EPS Q/Q89.87% SMA20-0.93% Beta1.38 Target Price9.00
Payout- Debt/Eq0.01 Sales Q/Q- SMA50-5.83% Rel Volume0.25 Prev Close0.70
Employees8 LT Debt/Eq0.00 EarningsMay 09 SMA200-59.39% Avg Volume295.04K Price0.68
IPODec 20, 2006 Option/ShortNo / No EPS/Sales Surpr.32.86% - Trades Volume73,571 Change-2.84%
May-27-25 08:30AM
May-06-25 08:30AM
May-01-25 08:30AM
Apr-09-25 08:30AM
Mar-14-25 08:30AM
08:30AM Loading…
Mar-12-25 08:30AM
Mar-04-25 08:30AM
Feb-20-25 08:45AM
Feb-19-25 09:00AM
Feb-10-25 08:45AM
Jan-29-25 08:45AM
Jan-22-25 08:00AM
Jan-16-25 08:00AM
Jan-03-25 05:20PM
Dec-17-24 08:30AM
04:05PM Loading…
Dec-13-24 04:05PM
Dec-12-24 12:05PM
Dec-03-24 08:15AM
Nov-21-24 08:15AM
Nov-14-24 09:00AM
Nov-12-24 08:45AM
Nov-07-24 08:30AM
Oct-31-24 08:30AM
Oct-15-24 08:00AM
Oct-10-24 08:30AM
Oct-08-24 08:00AM
Sep-25-24 08:00AM
Sep-16-24 08:00AM
Sep-05-24 08:00AM
Aug-19-24 08:00AM
08:05AM Loading…
Aug-13-24 08:05AM
Aug-08-24 08:00AM
Jul-31-24 09:15AM
Jul-29-24 08:30AM
Jul-19-24 08:30AM
Jul-11-24 08:00AM
Jun-24-24 09:00AM
Jun-21-24 08:15AM
Jun-17-24 08:00AM
Jun-14-24 09:55AM
Jun-11-24 08:30AM
Jun-10-24 09:15AM
08:00AM
May-21-24 08:30AM
May-14-24 08:05AM
May-13-24 10:53PM
May-07-24 08:30AM
07:30AM
May-02-24 08:30AM
May-01-24 08:30AM
Apr-23-24 08:30AM
Apr-16-24 11:22AM
08:30AM
Apr-11-24 09:15AM
Apr-10-24 08:15AM
Apr-03-24 05:30PM
Mar-27-24 08:00AM
Mar-26-24 11:52PM
Feb-15-24 08:35AM
Feb-13-24 08:35AM
Feb-08-24 02:40PM
08:05AM
Jan-30-24 09:25AM
Jan-29-24 02:01PM
08:05AM
Jan-09-24 08:00AM
Dec-29-23 04:52AM
Dec-28-23 08:00AM
Nov-10-23 08:05AM
Oct-18-23 10:00AM
Oct-11-23 09:05AM
Sep-14-23 07:13PM
Sep-11-23 04:01PM
08:35AM
Sep-07-23 08:30AM
Sep-06-23 08:45AM
Aug-11-23 08:05AM
Aug-09-23 08:05AM
Jul-05-23 08:45AM
Jun-22-23 08:30AM
Jun-14-23 08:45AM
Jun-01-23 08:45AM
May-24-23 08:45AM
May-17-23 08:30AM
May-12-23 08:05AM
May-11-23 09:05AM
Apr-06-23 09:00AM
Apr-05-23 08:35AM
Apr-04-23 08:30AM
Apr-03-23 08:30AM
Mar-23-23 08:05AM
Mar-15-23 08:30AM
Mar-01-23 09:05AM
Feb-08-23 08:35AM
Jan-11-23 01:00PM
Jan-10-23 08:35AM
Jan-09-23 08:45AM
Jan-04-23 05:15PM
Dec-30-22 08:45AM
Dec-16-22 08:05AM
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williams Donald AllenDirectorNov 21 '24Option Exercise0.003880728Nov 22 04:00 PM
Wei BinxianDirectorNov 21 '24Option Exercise0.003880855Nov 22 04:00 PM